International Clinical Trial: Research on intervention targets for autism spectrum disorder based on characteristic gut microbiota in Guangxi

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132160) titled 'Research on intervention targets for autism spectrum disorder based on characteristic gut microbiota in Guangxi' on Sept. 10.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Guangxi Medical University

Condition: autism spectrum disorder, ASD

Intervention: Rehabilitation Intervention Group:1. ABA behavioral intervention 2. Sensory integration training 3. Speech therapy. Lactobacillus plantarum PS128 treatment group:Oral Probiotics (Lactobacillus plantarum PS128)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-10 ...